Teladoc Health (TDOC)
(Delayed Data from NYSE)
$9.23 USD
-0.28 (-2.94%)
Updated Nov 8, 2024 04:00 PM ET
After-Market: $9.27 +0.04 (0.43%) 7:58 PM ET
3-Hold of 5 3
A Value A Growth F Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$9.23 USD
-0.28 (-2.94%)
Updated Nov 8, 2024 04:00 PM ET
After-Market: $9.27 +0.04 (0.43%) 7:58 PM ET
3-Hold of 5 3
A Value A Growth F Momentum A VGM
Zacks News
Healthcare Q2 Earnings Due on Aug 2: HUM, PRXL, MOH, TDOC
by Zacks Equity Research
The Medical sector is likely to benefit from inorganic growth, product launches, technology upgrades. However, regulatory hassles might offset its growth potential.
Will Teladoc (TDOC) Pull Off a Surprise in Q2 Earnings?
by Zacks Equity Research
Teladoc's (TDOC) second-quarter earnings may be driven by higher revenues and increased membership, partly offset by an increase in operating expenses.
Teladoc (TDOC) to Raise Debt for Best Doctors Acquisition
by Zacks Equity Research
Teladoc, Inc. (TDOC) announced recently that it would offer senior notes worth $200 million, with the year of maturity fixed as 2022.
Teladoc (TDOC) to Buy Best Doctors, Stock Hits New High
by Zacks Equity Research
Teladoc Inc. (TDOC) has inked a definitive agreement to acquire Best Doctors, a leader in medical consultation.
Teladoc (TDOC) Up 17% Since Earnings Report: Can It Continue?
by Zacks Equity Research
Teladoc (TDOC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Teladoc Hits 52-Week High on Strong Results, Client Wins
by Zacks Equity Research
Teladoc's (TDOC) 52-week high is believed to have been driven by the company's better-than-expected first-quarter earnings along with the recent news of expansion of its telehealth offerings in Texas.
Teladoc (TDOC) Q1 Loss Lower Than Expected, '17 View Intact
by Zacks Equity Research
Teladoc Inc.'s (TDOC) operating loss of 30 cents per share came in narrower than the Zacks Consensus Estimate of a loss of 33 cents per share.
What's in Store for Teladoc (TDOC) this Earnings Season?
by Zacks Equity Research
Our proven model does not conclusively show that Teladoc is likely to beat on earnings this quarter.
Teladoc to Boost Jefferson Health's Telehealth Platform
by Zacks Equity Research
Teladoc's (TDOC) services will complement JeffConnect, the telehealth program of Jefferson Health.
Teladoc (TDOC) Up 7% Since Earnings Report: Can It Continue?
by Zacks Equity Research
Teladoc (TDOC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Teladoc Continues to Grow in Booming Telehealth Industry
by Zacks Equity Research
Teladoc Inc. (TDOC), a premier telehealth services provider, is rapidly expanding its business in the booming telehealth services industry.
Teladoc (TDOC) Q4 Loss Lower Than Expected, Guides for '17
by Zacks Equity Research
Teladoc Inc.'s (TDOC) fourth-quarter operating loss of 31 cents per share came in narrower than the Zacks Consensus Estimate of a loss of 35 cents per share.
Should You Sell Teladoc (TDOC) Before Earnings?
by Zacks Equity Research
Given that Teladoc (TDOC) has a Zacks Rank #3 (Hold) and an ESP in positive territory, investors might want to consider this stock ahead of earnings
Teladoc (TDOC) to Report Q4 Earnings: What's in Store? (revised)
by Zacks Equity Research
Telehealth provider Teladoc Inc. (TDOC) has not confirmed the time/date for its December-quarter earnings release yet, but the report will likely be fairly soon, as they last reported quarterly results on October 27, 2016.
Teladoc (TDOC) to Report Q4 Earnings: What's in Store?
by Zacks Equity Research
Telehealth provider, Teladoc Inc. (TDOC ) is scheduled to report fourth-quarter and full-year 2016 results on Jan 27.
Teladoc Announces Stock Sale to Finance Growing Business
by Zacks Equity Research
Teladoc Inc. (TDOC) has announced to sell 5,400,000 shares of its common stock, in an effort to procure funds for expansion.
Teladoc's Client UnitedAg Expands Pact to Get Wider Services
by Zacks Equity Research
Teladoc Inc.'s (TDOC) existing client UnitedAg has expanded its partnership with the former.
Zacks.com featured highlights: Teladoc, United States Steel, Foresight Energy, Apache and ServisFirst Bancshares
by Zacks Equity Research
Zacks.com featured highlights: Teladoc, United States Steel, Foresight Energy, Apache and ServisFirst Bancshares
Teladoc (TDOC) Guidance Reflects Solid Business in '16, '17
by Zacks Equity Research
Teladoc's (TDOC), upbeat guidance for 2016 and 2017 points to strong business growth and superior performance.
Teladoc to Provide Diagnostic Service Via Analyte Health
by Zacks Equity Research
Teladoc (TDOC) has tied up with Analyte Health to provide lab diagnostics services through its telehealth platform.
Teladoc (TDOC) December Business Reveals Outperformance
by Zacks Equity Research
Teladoc Inc. (TDOC) disclosed that in the month of December it crossed more than two million patient visits.
Teladoc November Visits Set Record: Why is Stock Suffering?
by Zacks Equity Research
Teladoc Inc. (TDOC), the first and the largest telehealth company disclosed that the month of November witnessed a total of 101,600 patient visits.